Business Description
Onconetix Inc
NAICS : 541713
SIC : 2834
ISIN : US09610B1089
Description
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.3 | |||||
| Debt-to-EBITDA | -0.2 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -4.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -144.5 | |||||
| 3-Year EPS without NRI Growth Rate | -96.2 | |||||
| 3-Year FCF Growth Rate | -71.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.52 | |||||
| 9-Day RSI | 19.5 | |||||
| 14-Day RSI | 21.04 | |||||
| 6-1 Month Momentum % | -81.1 | |||||
| 12-1 Month Momentum % | -85.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.06 | |||||
| Quick Ratio | 0.05 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 69.04 | |||||
| Days Sales Outstanding | 32.79 | |||||
| Days Payable | 561.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -26.5 | |||||
| Shareholder Yield % | 13.09 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -39.14 | |||||
| Operating Margin % | -840.64 | |||||
| Net Margin % | -2759.57 | |||||
| FCF Margin % | -744.17 | |||||
| ROA % | -82.75 | |||||
| ROIC % | -22.1 | |||||
| ROC (Joel Greenblatt) % | -29097 | |||||
| ROCE % | -115.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.11 | |||||
| PB Ratio | 0.08 | |||||
| EV-to-EBIT | -0.39 | |||||
| EV-to-EBITDA | -0.4 | |||||
| EV-to-Revenue | 10.58 | |||||
| EV-to-FCF | -1.42 | |||||
| Earnings Yield (Greenblatt) % | -256.41 | |||||
| FCF Yield % | -493.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ONCO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Onconetix Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.87 | ||
| EPS (TTM) ($) | -99.52 | ||
| Beta | 0 | ||
| Volatility % | 120.52 | ||
| 14-Day RSI | 21.04 | ||
| 14-Day ATR ($) | 0.138859 | ||
| 20-Day SMA ($) | 0.53069 | ||
| 12-1 Month Momentum % | -85.66 | ||
| 52-Week Range ($) | 0.3303 - 21.4 | ||
| Shares Outstanding (Mil) | 8.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Onconetix Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Onconetix Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Onconetix Inc Frequently Asked Questions
What is Onconetix Inc(ONCO)'s stock price today?
The current price of ONCO is $0.32. The 52 week high of ONCO is $21.40 and 52 week low is $0.33.
When is next earnings date of Onconetix Inc(ONCO)?
The next earnings date of Onconetix Inc(ONCO) is 2025-03-10 Est..
Does Onconetix Inc(ONCO) pay dividends? If so, how much?
Onconetix Inc(ONCO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers